Ohr Pharmaceutical, Inc.
(NASDAQ : OHRP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.55%89.141.3%$797.85m
AMGNAmgen Inc.
1.08%187.501.2%$644.97m
GILDGilead Sciences, Inc.
0.29%65.740.9%$476.37m
BIIBBiogen Inc.
1.30%325.331.3%$432.61m
ILMNIllumina, Inc.
1.41%301.063.5%$311.78m
REGNRegeneron Pharmaceuticals, Inc.
0.93%422.522.6%$280.54m
VRTXVertex Pharmaceuticals Incorporated
1.48%185.761.9%$246.69m
ALXNAlexion Pharmaceuticals, Inc.
1.71%129.732.0%$214.36m
SRPTSarepta Therapeutics, Inc.
2.52%139.9815.4%$157.00m
AAgilent Technologies, Inc.
0.67%78.411.6%$155.05m
EXASExact Sciences Corporation
10.52%92.0425.3%$150.72m
INCYIncyte Corporation
1.82%84.852.5%$112.02m
ARRYArray BioPharma Inc.
2.33%23.248.2%$111.41m
NBIXNeurocrine Biosciences, Inc.
2.07%78.915.1%$80.47m
EXELExelixis, Inc.
1.41%21.526.4%$79.74m

Company Profile

Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY.